Capital Projects Supply Chain Impacts: Pre & Post Pandemic

Covid has completely disrupted traditional supply chain systems across the world, including in the pharmaceutical industry. The industry has had to adapt and change to the new emerging world. What does this mean for Capital Projects Supply Chains? Join us to find out the future state of the Pharmaceutical CapEx Supply Chain!


Kevin Batche

Kevin Batche

Senior Director Procurement & Logistics, Senior Associate, IPS

Mr. Batche has spent over 25 years delivering key assets in the Manufacturing, Pharmaceutical and Heavy Industries, globally. Director-level roles at Fuch’s Systems, Danieli, Wyeth and IPS have afforded him a view of these industries from the points of view of the OEM, Owner and EPCMV services provider, respectively. From Design through Procurement, Fabrication, Shipping and Construction – he has provided insight and solutions to improve overall CapEx performance.

A Mechanical Engineer by profession Kevin has a compulsion towards gathering data and evaluating the underlying stories. He lives with his wife, daughter (Temple), son (Pottsgrove High School) and dog and cat in Lower Pottsgrove, PA. He has also lived in NJ, NC, OH, Germany and Italy.

Registration Information:



ISPE Members




Emerging Leaders/Student


Group/Multiple Participants (in one sitting) $50

Brought to you by the Emerging Leaders Committee (formerly YP Committee) but open to all!

Register Now!